Literature DB >> 30481588

The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.

Edward Pajarillo1, Asha Rizor1, Jayden Lee2, Michael Aschner3, Eunsook Lee4.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (AD), and the most prevalent movement disorder. PD is characterized by dopaminergic neurodegeneration in the substantia nigra, but its etiology has yet to be established. Among several genetic variants contributing to PD pathogenesis, α-synuclein and leucine-rich repeat kinase (LRRK2) are widely associated with neuropathological phenotypes in familial and sporadic PD. α-Synuclein and LRRK2 found in Lewy bodies, a pathogenic hallmark of PD, are often posttranslationally modified. As posttranslational modifications (PTMs) are key processes in regulating the stability, localization, and function of proteins, PTMs have emerged as important modulators of α-synuclein and LRRK2 pathology. Aberrant PTMs altering phosphorylation, ubiquitination, nitration and truncation of these proteins promote PD pathogenesis, while other PTMs such as sumoylation may be protective. Although the causes of many aberrant PTMs are unknown, environmental risk factors may contribute to their aberrancy. Environmental toxicants such as rotenone and paraquat have been shown to interact with these proteins and promote their abnormal PTMs. Notably, manganese (Mn) exposure leads to a PD-like neurological disorder referred to as manganism-and induces pathogenic PTMs of α-synuclein and LRRK2. In this review, we highlight the role of PTMs of α-synuclein and LRRK2 in PD pathogenesis and discuss the impact of environmental risk factors on their aberrancy.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  LRRK2; Manganese; Parkinson's disease; Posttranslational modifications; α-Synuclein

Year:  2018        PMID: 30481588      PMCID: PMC6534484          DOI: 10.1016/j.bbadis.2018.11.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  10 in total

1.  Neurotoxicity mechanisms of manganese in the central nervous system.

Authors:  Edward Pajarillo; Ivan Nyarko-Danquah; Getinet Adinew; Asha Rizor; Michael Aschner; Eunsook Lee
Journal:  Adv Neurotoxicol       Date:  2021-01-27

2.  Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.

Authors:  Stylianos Ravanidis; Anastasia Bougea; Dimitra Karampatsi; Nikolaos Papagiannakis; Matina Maniati; Leonidas Stefanis; Epaminondas Doxakis
Journal:  Mov Disord       Date:  2021-01-12       Impact factor: 10.338

3.  Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies.

Authors:  Lone Fjord-Larsen; Annemette Thougaard; Karen Malene Wegener; Joan Christiansen; Frank Larsen; Lise Maj Schrøder-Hansen; Marianne Kaarde; Dorte Kornerup Ditlevsen
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

4.  Human Brain and Blood N-Glycome Profiling in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.

Authors:  Lei Yu; Zhiguang Huo; Jingyun Yang; Helena Palma-Gudiel; Patricia A Boyle; Julie A Schneider; David A Bennett; Jinying Zhao
Journal:  Front Aging Neurosci       Date:  2021-10-27       Impact factor: 5.750

5.  α-Synuclein arginylation in the human brain.

Authors:  Jun Zhao; Buyan Pan; Marie Fina; Yun Huang; Marie Shimogawa; Kelvin C Luk; Elizabeth Rhoades; E James Petersson; Dawei W Dong; Anna Kashina
Journal:  Transl Neurodegener       Date:  2022-04-08       Impact factor: 8.014

6.  Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.

Authors:  Qiong Cheng; Juan Chen; Hui Guo; Jin-Li Lu; Jing Zhou; Xin-Yu Guo; Yue Shi; Yu Zhang; Shu Yu; Qi Zhang; Fei Ding
Journal:  Acta Pharmacol Sin       Date:  2020-08-28       Impact factor: 6.150

7.  Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.

Authors:  Stylianos Ravanidis; Anastasia Bougea; Nikolaos Papagiannakis; Christos Koros; Athina Maria Simitsi; Ioanna Pachi; Marianthi Breza; Leonidas Stefanis; Epaminondas Doxakis
Journal:  Ann Clin Transl Neurol       Date:  2020-08-29       Impact factor: 4.511

8.  LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia.

Authors:  Judong Kim; Edward Pajarillo; Asha Rizor; Deok-Soo Son; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

9.  Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson's Disease Models.

Authors:  Yu Zhang; Hui Guo; Xinyu Guo; Denfeng Ge; Yue Shi; Xiyu Lu; Jinli Lu; Juan Chen; Fei Ding; Qi Zhang
Journal:  Int J Environ Res Public Health       Date:  2019-10-10       Impact factor: 3.390

Review 10.  Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications.

Authors:  Rosie Bell; Michele Vendruscolo
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.